Overview
Rajasree Roy is a Hematologist Oncology specialist and a Palliative Medicine provider in Greenvale, New York. Dr. Roy is rated as an Experienced provider by MediFind in the treatment of Prothrombin Deficiency. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2200 Northern Blvd, Suite 111, Greenvale, NY 11548
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Barnabas Health Medical Group PC
Stephen Abo is a Hematologist Oncology specialist and a Hematologist in Belleville, New Jersey. Dr. Abo is rated as a Distinguished provider by MediFind in the treatment of Prothrombin Deficiency. His top areas of expertise are Shwartzman Phenomenon, Venous Thromboembolism (VTE), Inflammatory Breast Cancer, and Angiosarcoma. Dr. Abo is currently accepting new patients.
Icahn School Of Medicine At Mount Sinai
Christopher Walsh is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Walsh is rated as a Distinguished provider by MediFind in the treatment of Prothrombin Deficiency. His top areas of expertise are Hemophilia A, Hemophilic Arthropathy, Hemophilia B, Factor 11 Deficiency, and Bone Marrow Aspiration.
North Shore Hematology Oncology Associates PC
Fauzia Paracha is a Hematologist Oncology specialist and a Hematologist in Smithtown, New York. Dr. Paracha is rated as a Distinguished provider by MediFind in the treatment of Prothrombin Deficiency. Her top areas of expertise are Anemia, Vitamin B12 Deficiency, Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Roy isDistinguished. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Roy isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Roy isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Roy isAdvanced. Learn about Anemia.
- Breast CancerDr. Roy isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency Anemia
- Colorectal CancerDr. Roy isAdvanced. Learn about Colorectal Cancer.
- Congenital Antithrombin 3 Deficiency
- Experienced
- Acquired HemophiliaDr. Roy isExperienced. Learn about Acquired Hemophilia.
- Acute Lymphoblastic Leukemia (ALL)
- Acute Mountain SicknessDr. Roy isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Roy isExperienced. Learn about Acute Myeloid Leukemia (AML).